Vyvadenta - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 63,857 | 56,425 | 163,405 | 242,465 | 336,931 | 384,762 | 363,565 | 450,524 |
| Profit before tax | -1,002 | 7,520 | 31,467 | 78,141 | 118,568 | 113,719 | 74,628 | 200,648 |
| Net profit | -1,002 | 7,239 | 29,751 | 74,162 | 100,528 | 95,924 | 65,111 | 168,686 |
| Equity | 271 | 7,510 | 37,261 | 111,423 | 211,951 | 154,934 | 184,751 | 300,496 |
| Liabilities | 183 | 3,596 | 4,332 | 4,619 | 66,903 | 78,544 | 36,818 | 126,752 |
| Non-current assets | 0 | 3,651 | 3,495 | 21,763 | 83,393 | 72,421 | 66,996 | 185,663 |
| Current assets | 454 | 1,418 | 38,082 | 90,799 | 193,484 | 159,647 | 153,146 | 239,552 |
| Total assets | 454 | 5,069 | 41,577 | 112,562 | 276,877 | 232,068 | 220,142 | 425,215 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 65,696 | 55,818 | 43,067 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | -11.6% | +189.6% | +48.4% | +39.0% | +14.2% | -5.5% | +23.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -220.7% | 142.8% | 71.6% | 65.9% | 36.3% | 41.3% | 29.6% | 39.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -369.7% | 96.4% | 79.8% | 66.6% | 47.4% | 61.9% | 35.2% | 56.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -1.6% | 12.8% | 18.2% | 30.6% | 29.8% | 24.9% | 17.9% | 37.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -1.6% | 13.3% | 19.3% | 32.2% | 35.2% | 29.6% | 20.5% | 44.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.7 | 0.5 | 0.1 | 0.0 | 0.3 | 0.5 | 0.2 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 63,857 | 18,808 | 54,468 | 80,822 | 112,310 | 128,254 | 121,188 | 150,175 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vyvadenta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-03-27 | 2026-03-27 | 4.17 |
| 2026-03-17 | 2026-03-23 | 4.17 |
| 2026-02-18 | 2026-02-18 | 152.76 |
| 2026-01-22 | 2026-01-27 | 3.80 |
| 2026-01-16 | 2026-01-19 | 0.78 |
| 2025-12-16 | 2025-12-22 | 1671.69 |
| 2025-11-18 | 2025-12-15 | 0.78 |
| 2025-10-27 | 2025-11-03 | 0.78 |
| 2025-10-23 | 2025-10-26 | 104.72 |
| 2025-10-16 | 2025-10-22 | 103.94 |
| 2025-09-16 | 2025-10-13 | 103.94 |
| 2025-01-16 | 2025-01-19 | 0.48 |
| 2024-11-18 | 2024-12-04 | 0.48 |
| 2024-10-16 | 2024-11-10 | 0.48 |
| 2024-09-17 | 2024-10-01 | 0.48 |
| 2024-08-19 | 2024-09-11 | 0.48 |
| 2024-07-16 | 2024-08-07 | 0.48 |
| 2024-06-18 | 2024-07-08 | 0.48 |
| 2024-05-16 | 2024-06-11 | 0.48 |
| 2024-04-16 | 2024-05-06 | 0.48 |
| 2024-03-18 | 2024-04-10 | 0.48 |
| 2024-02-19 | 2024-03-11 | 0.48 |
| 2024-01-16 | 2024-02-11 | 0.48 |
| 2023-12-18 | 2023-12-27 | 0.48 |
| 2023-11-16 | 2023-12-12 | 0.48 |
| 2023-10-17 | 2023-11-12 | 0.48 |
| 2023-09-18 | 2023-10-10 | 0.48 |
| 2023-08-17 | 2023-09-11 | 0.48 |
| 2023-07-18 | 2023-08-07 | 0.48 |
| 2023-06-16 | 2023-07-10 | 0.48 |
| 2023-05-16 | 2023-06-11 | 0.48 |
| 2023-05-02 | 2023-05-10 | 0.48 |
| 2023-04-18 | 2023-04-28 | 0.48 |
| 2023-03-16 | 2023-04-05 | 0.48 |
| 2023-02-17 | 2023-03-12 | 0.48 |
| 2023-01-17 | 2023-01-31 | 0.48 |
| 2022-12-16 | 2022-12-29 | 0.48 |
| 2022-11-21 | 2022-12-12 | 0.48 |
| 2022-11-17 | 2022-11-18 | 0.48 |
| 2022-10-18 | 2022-11-10 | 0.48 |
| 2022-09-16 | 2022-10-12 | 0.48 |
| 2022-08-23 | 2022-09-12 | 0.48 |
| 2022-07-18 | 2022-08-07 | 0.48 |
| 2022-06-16 | 2022-07-13 | 0.48 |
| 2022-05-17 | 2022-06-12 | 0.48 |
| 2022-04-19 | 2022-05-09 | 0.48 |
| 2022-03-16 | 2022-04-04 | 0.48 |
| 2022-02-17 | 2022-03-13 | 0.48 |
| 2022-01-18 | 2022-02-14 | 0.48 |
| 2021-12-16 | 2021-12-27 | 0.48 |
| 2021-11-16 | 2021-12-14 | 0.48 |
| 2021-10-18 | 2021-11-14 | 0.48 |
| 2021-09-16 | 2021-10-13 | 0.48 |
Vyvadenta - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-01-08 | 2025-01-15 | 375.33 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vyvadenta, UAB (code 304590697) is a private limited liability company engaged in dental practice care activities. In 2025, revenue increased to €450.5K, up 23.9% year on year and 17.1% over two years. Net profit rose to €168.7K, after €65.1K in 2024 and €95.9K in 2023, showing a clear recovery and stronger operating performance in the latest year. The profit margin improved to 37.4% in 2025 from 17.9% in 2024 and 24.9% in 2023. Total assets declined to €185.7K in 2025 from €220.1K in 2024 and €232.1K in 2023, while equity increased to €300.5K from €184.8K and €154.9K over the same period. Reported profitability ratios were very strong, with ROE at 56.1% and ROA at 90.9% in 2025. Asset turnover reached 2.43x. Based on staffing metrics, revenue per employee was €150.2K and profit per employee €56.2K, indicating solid productivity.